Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00267293 · ClinicalTrials.gov registry record · Phase 4

Ibuprofen Alone and in Combination With Acetaminophen for Treatment of Fever

A Phase 4 study of Fever, sponsored by Penn State University.

Completed
Registry status
Phase 4
Development phase
60
Enrollment target
1
Study location

NCT00267293 is a Phase 4 study of Fever that has completed, run by Penn State University. The registered enrollment target is 60 participants, below the 596-participant average among 18 other Fever trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00267293, a Phase 4 study of Fever, has completed, sponsored by Penn State University.

COMPLETED
Registry status
Phase 4
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Currently, when a child has fever either ibuprofen (e.g. Motrin, Advil) or acetaminophen (e.g. Tylenol) is given. Both Ibuprofen and Acetaminophen are approved for over the counter use for treatment of fever by the Food and Drug Administration (FDA). This study hopes to determine whether giving both medications together is better than giving one medication alone for the treatment of fever.

Conditions Studied

Interventions

  • DRUG Acetaminophen
  • DRUG Ibuprofen

Study Locations (1)

Pennsylvania

  • Penn State Milton S. Hershey Medical Center - Hershey

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2006-01
Est. Completion 2009-06
Phase Phase 4

Sponsor

Penn State University

219 total trials

What the Registry Record Tells You About NCT00267293

The ClinicalTrials.gov registry entry for NCT00267293 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 596-participant average among 18 other Fever trials with a reported enrollment target (90% lower). The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Fever appearing as the primary indexed condition, and to 2 interventions - of which Acetaminophen is the first listed.

NCT00267293 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00267293 about?

NCT00267293 is a clinical study titled "Ibuprofen Alone and in Combination With Acetaminophen for Treatment of Fever". Currently, when a child has fever either ibuprofen (e.g. Motrin, Advil) or acetaminophen (e.g. Tylenol) is given. Both Ibuprofen and Acetaminophen are approved for over the counter use for treatment of fever by the Food and Drug Administration (FDA). This study hopes to determine whether giving both...

What is the current status of trial NCT00267293?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2006-01. Estimated completion is 2009-06.

What conditions does trial NCT00267293 study?

This clinical trial studies the following conditions: Fever.

What interventions are being tested in trial NCT00267293?

The interventions under investigation include: Acetaminophen (DRUG), Ibuprofen (DRUG).

Who is sponsoring clinical trial NCT00267293?

This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00267293 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fever

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.